A review of the current mammalian models of Alzheimer's disease and challenges that need to be overcome
NE Mckean, RR Handley, RG Snell - International journal of molecular …, 2021 - mdpi.com
Alzheimer's disease (AD) is one of the looming health crises of the near future. Increasing
lifespans and better medical treatment for other conditions mean that the prevalence of this …
lifespans and better medical treatment for other conditions mean that the prevalence of this …
Going beyond established model systems of Alzheimer's disease: companion animals provide novel insights into the neurobiology of aging
AA de Sousa, BA Rigby Dames, EC Graff… - Communications …, 2023 - nature.com
Alzheimer's disease (AD) is characterized by brain plaques, tangles, and cognitive
impairment. AD is one of the most common age-related dementias in humans. Progress in …
impairment. AD is one of the most common age-related dementias in humans. Progress in …
Associations between physical activity and cognitive dysfunction in older companion dogs: Results from the Dog Aging Project
EE Bray, DA Raichlen, KK Forsyth, DEL Promislow… - GeroScience, 2023 - Springer
Canine cognitive dysfunction (CCD) is a form of dementia that shares many similarities with
Alzheimer's disease. Given that physical activity is believed to reduce risk of Alzheimer's …
Alzheimer's disease. Given that physical activity is believed to reduce risk of Alzheimer's …
Protecting human and animal health: the road from animal models to new approach methods
BLF Kaplan, AM Hoberman, W Slikker, MA Smith… - Pharmacological …, 2024 - ASPET
Animals and animal models have been invaluable for our current understanding of human
and animal biology, including physiology, pharmacology, biochemistry, and disease …
and animal biology, including physiology, pharmacology, biochemistry, and disease …
Electroencephalographic signatures of dogs with presumptive diagnosis of canine cognitive dysfunction
Canine cognitive dysfunction (CCD) is a highly prevalent neurodegenerative disease
considered the canine analog of early Alzheimer's disease (AD). Unfortunately, CCD cannot …
considered the canine analog of early Alzheimer's disease (AD). Unfortunately, CCD cannot …
Assessment of risk factors in dogs with presumptive advanced canine cognitive dysfunction
B MacQuiddy, JA Moreno, B Kusick… - Frontiers in Veterinary …, 2022 - frontiersin.org
Objectives The aim of this study was to investigate the potential risk factors involved in the
development of presumptive advanced canine cognitive dysfunction (pACCD). Materials …
development of presumptive advanced canine cognitive dysfunction (pACCD). Materials …
PET imaging in animal models of alzheimer's disease
B Chen, B Marquez-Nostra, E Belitzky… - Frontiers in …, 2022 - frontiersin.org
The successful development and translation of PET imaging agents targeting β-amyloid
plaques and hyperphosphorylated tau tangles have allowed for in vivo detection of these …
plaques and hyperphosphorylated tau tangles have allowed for in vivo detection of these …
[HTML][HTML] Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
AD Hines, S McGrath, AS Latham, B Kusick… - Frontiers in Aging …, 2023 - frontiersin.org
Canine cognitive dysfunction (CCD) syndrome is a well-recognized naturally occurring
disease in aged dogs, with a remarkably similar disease course, both in its clinical …
disease in aged dogs, with a remarkably similar disease course, both in its clinical …
Inhibition of NLRP1-Dependent Pyroptosis Prevents Glycogen Synthase Kinase-3β Overactivation–Induced Hyperphosphorylated Tau in Rats
X Liu, W Song, Y Yu, J Su, X Shi, X Yang, H Wang… - Neurotoxicity …, 2022 - Springer
Our previous study indicated that inhibition of NLRP1-dependent pyroptosis could decrease
intracerebroventricular (ICV) injection of a protein kinase A (PKA) agonist–or streptozotocin …
intracerebroventricular (ICV) injection of a protein kinase A (PKA) agonist–or streptozotocin …
Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial
Background Older companion dogs naturally develop a dementia-like syndrome with
biological, clinical and therapeutic similarities to Alzheimer disease (AD). Given there has …
biological, clinical and therapeutic similarities to Alzheimer disease (AD). Given there has …